{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:13:43Z","timestamp":1792188823597,"version":"4.4.0"},"reference-count":260,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.immuni.2019.03.028","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:01:42Z","timestamp":1555412502000},"page":"832-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":383,"title":["The \u03b3c Family of Cytokines: Basic Biology to Therapeutic Ramifications"],"prefix":"10.1016","volume":"50","author":[{"given":"Warren J.","family":"Leonard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2019.03.028_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2019.03.028_bib2","doi-asserted-by":"crossref","first-page":"29265","DOI":"10.1074\/jbc.271.46.29265","article-title":"cDNA cloning and characterization of the human interleukin 13 receptor alpha chain","volume":"271","author":"Aman","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.immunol.23.021704.115821","article-title":"Regulation of Th2 differentiation and Il4 locus accessibility","volume":"24","author":"Ansel","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","article-title":"Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex","volume":"167","author":"Asao","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib5","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1182\/blood-2011-10-388546","article-title":"IL-21 inhibits T\u00a0cell IL-2 production and impairs Treg homeostasis","volume":"119","author":"Attridge","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0092-8674(90)90182-E","article-title":"Shared architecture of hormone binding domains in type I and II interferon receptors","volume":"61","author":"Bazan","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib9","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor superfamily","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ni.2794","article-title":"STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling","volume":"15","author":"Begitt","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clim.2014.09.012","article-title":"Safety, efficacy, and pharmacokinetics\/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia\/lymphoma","volume":"155","author":"Berkowitz","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib12","doi-asserted-by":"crossref","first-page":"eaak9741","DOI":"10.1126\/scisignal.aak9741","article-title":"Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7","volume":"10","author":"Bi","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.immuni.2019.03.028_bib13","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T\u00a0cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4049\/jimmunol.178.1.280","article-title":"IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T\u00a0cells","volume":"178","author":"Burchill","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.immuni.2018.03.012","article-title":"Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells","volume":"48","author":"Burrack","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41598-018-19315-z","article-title":"Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy","volume":"8","author":"Buttrick","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2019.03.028_bib17","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1038\/ncomms15366","article-title":"Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4","volume":"8","author":"Campos Carrascosa","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.028_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI119258","article-title":"A potential role for interleukin-15 in the regulation of human natural killer cell survival","volume":"99","author":"Carson","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.028_bib19","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b01308","article-title":"Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors","author":"Casimiro-Garcia","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib20","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.immuni.2017.07.015","article-title":"CCCTC-Binding Factor Translates Interleukin 2- and \u03b1-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs","volume":"47","author":"Chisolm","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13073-018-0580-z","article-title":"T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency","volume":"10","author":"Clarke","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0008-8749(74)90066-5","article-title":"Commentary. Similarities of T\u00a0cell function in cell-mediated immunity and antibody production","volume":"12","author":"Cohen","year":"1974","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib26","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.178.5.2827","article-title":"IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production","volume":"178","author":"Coquet","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.immuni.2015.07.015","article-title":"Interleukin-21-Producing CD4(+) T Cells Promote Type 2 Immunity to House Dust Mites","volume":"43","author":"Coquet","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/312768a0","article-title":"Cloning, sequence and expression of human interleukin-2 receptor","volume":"312","author":"Cosman","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2010.10.012","article-title":"Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2","volume":"33","author":"Crellin","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/imr.12135","article-title":"Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy","volume":"257","author":"Crompton","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2019.03.028_bib31","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1128\/MCB.16.9.4710","article-title":"A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9","volume":"16","author":"Demoulin","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4049\/jimmunol.1600019","article-title":"IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector\/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists","volume":"197","author":"Desbois","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib33","doi-asserted-by":"crossref","first-page":"eaao2933","DOI":"10.1126\/science.aao2933","article-title":"Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T\u00a0cells","volume":"361","author":"DiToro","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.4049\/jimmunol.150.3.960","article-title":"Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2","volume":"150","author":"Djeu","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","article-title":"IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells","volume":"17","author":"Dubois","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib37","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/eji.1830230743","article-title":"Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes","volume":"23","author":"Dugas","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/327518a0","article-title":"A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors","volume":"327","author":"Dukovich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib41","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1038\/nrdp.2015.61","article-title":"Severe combined immunodeficiencies and related disorders","volume":"1","author":"Fischer","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.immuni.2019.03.028_bib42","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T\u00a0cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib43","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.4049\/jimmunol.168.5.2212","article-title":"Positive effects of glucocorticoids on T\u00a0cell function by up-regulation of IL-7 receptor alpha","volume":"168","author":"Franchimont","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.40054","article-title":"Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis","volume":"69","author":"Genovese","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.immuni.2019.03.028_bib45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ni.2920","article-title":"TH9 cells that express the transcription factor PU.1 drive T\u00a0cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells","volume":"15","author":"Gerlach","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.0105-2896.2005.00234.x","article-title":"Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients","volume":"203","author":"Giliani","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2019.03.028_bib48","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/j.1460-2075.1994.tb06576.x","article-title":"Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15","volume":"13","author":"Giri","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2019.03.028_bib49","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1073\/pnas.87.9.3440","article-title":"Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5\u2032 regulatory sequences","volume":"87","author":"Gnarra","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.86.1.302","article-title":"Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells","volume":"86","author":"Goodwin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib51","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.1003049","article-title":"A brief history of IL-9","volume":"186","author":"Goswami","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib257","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified \u03b3-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib53","doi-asserted-by":"crossref","first-page":"eaat6280","DOI":"10.1126\/science.aat6280","article-title":"Commensal-specific T\u00a0cell plasticity promotes rapid tissue adaptation to injury","volume":"363","author":"Harrison","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1126\/science.2785715","article-title":"Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA\u2019s","volume":"244","author":"Hatakeyama","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1073\/pnas.93.1.497","article-title":"Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor","volume":"93","author":"Hilton","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib56","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T\u00a0cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib57","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib58","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib59","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1126\/science.8085155","article-title":"An interleukin-4-induced transcription factor: IL-4 Stat","volume":"265","author":"Hou","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib258","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1084\/jem.155.3.914","article-title":"Identification of a T cell-derived b\u00a0cell growth factor distinct from interleukin 2","volume":"155","author":"Howard","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature22969","article-title":"Fine-mapping inflammatory bowel disease loci to single-variant resolution","volume":"547","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib61","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ejhg.2012.3","article-title":"1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data","volume":"20","author":"Huang","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.immuni.2019.03.028_bib62","doi-asserted-by":"crossref","first-page":"e0132802","DOI":"10.1371\/journal.pone.0132802","article-title":"Comparative and Evolutionary Analysis of the Interleukin 17 Gene Family in Invertebrates","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2019.03.028_bib63","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/eji.1830200632","article-title":"Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T\u00a0cell growth factor P40\/TCGFIII (interleukin 9)","volume":"20","author":"H\u00fcltner","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib64","doi-asserted-by":"crossref","first-page":"E7788","DOI":"10.1073\/pnas.1610544113","article-title":"Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T\u00a0cells","volume":"113","author":"Hurton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib65","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.188.11.2067","article-title":"Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity","volume":"188","author":"Imada","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.01.042","article-title":"IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation","author":"Impellizzieri","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib67","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1084\/jem.155.3.734","article-title":"T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells","volume":"155","author":"Isakson","year":"1982","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","article-title":"Cell biology of IL-7, a key lymphotrophin","volume":"16","author":"Jiang","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.immuni.2019.03.028_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis","volume":"173","author":"Jin","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1084\/jem.20111174","article-title":"STAT5 is a potent negative regulator of TFH cell differentiation","volume":"209","author":"Johnston","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri3824","article-title":"The development and in\u00a0vivo function of T helper 9 cells","volume":"15","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib259","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-7613(02)00295-9","article-title":"IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity","volume":"16","author":"Kasaian","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib74","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/313402a0","article-title":"Unique structure of murine interleukin-2 as deduced from cloned cDNAs","volume":"313","author":"Kashima","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib75","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ni.3716","article-title":"Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival","volume":"18","author":"Katerndahl","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib76","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T\u00a0cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib77","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.M501459200","article-title":"Calcium-dependent activation of interleukin-21 gene expression in T\u00a0cells","volume":"280","author":"Kim","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/intimm\/7.1.115","article-title":"Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex","volume":"7","author":"Kimura","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib79","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.immuni.2014.06.018","article-title":"The transcription factor T-bet is induced by IL-15 and thymic agonist selection and controls CD8\u03b1\u03b1(+) intraepithelial lymphocyte development","volume":"41","author":"Klose","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature23676","article-title":"The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation","volume":"549","author":"Klose","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib81","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1038\/s41467-018-07202-0","article-title":"A conserved enhancer regulates Il9 expression in multiple lineages","volume":"9","author":"Koh","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.028_bib82","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1126\/science.8266076","article-title":"Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4","volume":"262","author":"Kondo","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib83","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.8128231","article-title":"Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes","volume":"263","author":"Kondo","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib84","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T\u00a0cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib85","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib86","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib87","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2009.10.008","article-title":"Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors","volume":"31","author":"Kwon","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib89","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.172.3.921","article-title":"Generation of interleukin 4 (IL-4)-producing cells in\u00a0vivo and in\u00a0vitro: IL-2 and IL-4 are required for in\u00a0vitro generation of IL-4-producing cells","volume":"172","author":"Le Gros","year":"1990","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib90","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1074-7613(03)00179-1","article-title":"Regulation of the Th2 cytokine locus by a locus control region","volume":"19","author":"Lee","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib91","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","article-title":"Characterization of circulating T\u00a0cells specific for tumor-associated antigens in melanoma patients","volume":"5","author":"Lee","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib92","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.med.47.1.229","article-title":"The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling","volume":"47","author":"Leonard","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib93","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/35105066","article-title":"Cytokines and immunodeficiency diseases","volume":"1","author":"Leonard","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"Jaks and STATs: biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib95","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/311626a0","article-title":"Molecular cloning and expression of cDNAs for the human interleukin-2 receptor","volume":"311","author":"Leonard","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib96","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.3925551","article-title":"Localization of the gene encoding the human interleukin-2 receptor on chromosome 10","volume":"228","author":"Leonard","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib97","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 \u2018superkine\u2019","volume":"484","author":"Levin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib98","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib99","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri.2016.26","article-title":"T cell receptor signalling in the control of regulatory T\u00a0cell differentiation and function","volume":"16","author":"Li","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib100","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3389\/fimmu.2018.02738","article-title":"Chromatin Accessibility and Interactions in the Transcriptional Regulation of T Cells","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib101","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature11530","article-title":"BATF-JUN is critical for IRF4-mediated transcription in T\u00a0cells","volume":"490","author":"Li","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib102","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1073\/pnas.1714019114","article-title":"STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib103","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib104","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1073\/pnas.1301138111","article-title":"Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression","volume":"111","author":"Liao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib106","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1074\/jbc.271.18.10738","article-title":"Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells","volume":"271","author":"Lin","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib107","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.immuni.2012.02.017","article-title":"Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function","volume":"36","author":"Lin","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib108","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41467-017-01477-5","article-title":"Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.028_bib109","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.2540528","article-title":"Regulation of lymphokine messenger RNA stability by a surface-mediated T\u00a0cell activation pathway","volume":"244","author":"Lindstein","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib110","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1073\/pnas.92.19.8831","article-title":"Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue","volume":"92","author":"Liu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib111","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood.V94.9.3027","article-title":"Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach","volume":"94","author":"Lo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib112","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib113","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1074\/jbc.M513118200","article-title":"The structure of the interleukin-15 alpha receptor and its implications for ligand binding","volume":"281","author":"Lorenzen","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib114","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1084\/jem.166.4.1156","article-title":"Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor","volume":"166","author":"Lowenthal","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib115","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI65459","article-title":"Th9 cells promote antitumor immune responses in\u00a0vivo","volume":"122","author":"Lu","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.028_bib116","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib117","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"Mackall","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib118","doi-asserted-by":"crossref","first-page":"e1000322","DOI":"10.1371\/journal.pgen.1000322","article-title":"IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production","volume":"5","author":"Maier","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.immuni.2019.03.028_bib119","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(02)00367-9","article-title":"CD4 regulatory T\u00a0cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2","volume":"17","author":"Malek","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib121","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","article-title":"IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice","volume":"97","author":"Marks-Konczalik","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib122","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.celrep.2017.09.036","article-title":"Precocious Interleukin 21 Expression in Naive Mice Identifies a Natural Helper Cell Population in Autoimmune Disease","volume":"21","author":"Marnik","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2019.03.028_bib123","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2017.07.005","article-title":"Interleukin-7 Availability Is Maintained by a Hematopoietic Cytokine Sink Comprising Innate Lymphoid Cells and T Cells","volume":"47","author":"Martin","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib124","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.4147","article-title":"An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T\u00a0cells to TH17-like cells","volume":"22","author":"Massoud","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib300","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood-2008-02-137414","article-title":"Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP","volume":"112","author":"Mazzucchelli","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib126","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/S0140-6736(18)32483-8","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Mease","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.028_bib127","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.4049\/jimmunol.170.8.4111","article-title":"IL-21 induces the apoptosis of resting and activated primary B cells","volume":"170","author":"Mehta","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib128","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1203102","article-title":"Calcitonin gene-related peptide and cyclic adenosine 5\u2032-monophosphate\/protein kinase A pathway promote IL-9 production in Th9 differentiation process","volume":"190","author":"Mikami","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(96)01462-7","article-title":"Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4\/IL-13 receptor complex","volume":"401","author":"Miloux","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.immuni.2019.03.028_bib130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib131","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.immuni.2015.04.018","article-title":"Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps","volume":"42","author":"Mitra","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib132","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.7973659","article-title":"Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits","volume":"266","author":"Miyazaki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib133","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","article-title":"Selective in\u00a0vitro growth of T\u00a0lymphocytes from normal human bone marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib134","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3389\/fimmu.2018.01237","article-title":"Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges","volume":"9","author":"Moutuou","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1074-7613(00)80389-1","article-title":"An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction","volume":"7","author":"Nakajima","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 Cells in Health and Disease","volume":"35","author":"Nakayama","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib137","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gutjnl-2013-305947","article-title":"IL-9 and its receptor are predominantly involved in the pathogenesis of UC","volume":"64","author":"Nalleweg","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.immuni.2019.03.028_bib138","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/333571a0","article-title":"Stimulation of B-cell progenitors by cloned murine interleukin-7","volume":"333","author":"Namen","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib139","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/311631a0","article-title":"Molecular cloning of cDNA encoding human interleukin-2 receptor","volume":"311","author":"Nikaido","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib140","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.8266077","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor","volume":"262","author":"Noguchi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib141","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","article-title":"Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans","volume":"73","author":"Noguchi","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib142","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.1003009","article-title":"Intrinsic IL-21 signaling is critical for CD8 T\u00a0cell survival and memory formation in response to vaccinia viral infection","volume":"186","author":"Novy","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib143","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T\u00a0cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib144","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","article-title":"Generation of T follicular helper cells is mediated by interleukin-21 but independent of T\u00a0helper 1, 2, or 17 cell lineages","volume":"29","author":"Nurieva","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41584-018-0155-9","article-title":"Selective Janus kinase inhibitors come of age","volume":"15","author":"O\u2019Shea","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.immuni.2019.03.028_bib146","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni.2242","article-title":"Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile","volume":"13","author":"Oestreich","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib147","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib148","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2019.03.028_bib149","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.4049\/jimmunol.1800097","article-title":"Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis","volume":"200","author":"Owen","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41590-018-0289-6","article-title":"Thymic regulatory T\u00a0cells arise via two distinct developmental programs","volume":"20","author":"Owen","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib151","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.200360997","article-title":"Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain","volume":"97","author":"Ozaki","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib152","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib153","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","article-title":"Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6","volume":"173","author":"Ozaki","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib154","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/76923","article-title":"Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin","volume":"1","author":"Pandey","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1084\/jem.192.5.659","article-title":"Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor","volume":"192","author":"Park","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib156","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1073\/pnas.1317023110","article-title":"Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants","volume":"110","author":"Parker","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib157","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib158","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2015.01.038","article-title":"History of interleukin-4","volume":"75","author":"Paul","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.immuni.2019.03.028_bib159","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1084\/jem.180.5.1955","article-title":"Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice","volume":"180","author":"Peschon","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib160","doi-asserted-by":"crossref","first-page":"eaaf8612","DOI":"10.1126\/sciimmunol.aaf8612","article-title":"IL-10 induces a STAT3-dependent autoregulatory loop in TH2 cells that promotes Blimp-1 restriction of cell expansion via antagonism of STAT5 target genes","volume":"1","author":"Poholek","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib161","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/3877","article-title":"Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency","volume":"20","author":"Puel","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2019.03.028_bib162","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T\u00a0cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib163","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/MCB.15.6.3336","article-title":"Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis","volume":"15","author":"Quelle","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib164","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib165","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","article-title":"IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in\u00a0vivo","volume":"118","author":"Recher","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib166","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12862-018-1290-2","article-title":"Phylotranscriptomics suggests the jawed vertebrate ancestor could generate diverse helper and regulatory T\u00a0cell subsets","volume":"18","author":"Redmond","year":"2018","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib167","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.4049\/jimmunol.1401220","article-title":"The TNF-family ligand TL1A and its receptor DR3 promote T\u00a0cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T\u00a0cells","volume":"194","author":"Richard","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib168","doi-asserted-by":"crossref","first-page":"eaam7710","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib169","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1109745","article-title":"The structure of interleukin-2 complexed with its alpha receptor","volume":"308","author":"Rickert","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib170","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ni.2449","article-title":"Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15","volume":"13","author":"Ring","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib171","doi-asserted-by":"crossref","first-page":"14601","DOI":"10.1038\/ncomms14601","article-title":"IL-15 sustains IL-7R-independent ILC2 and ILC3 development","volume":"8","author":"Robinette","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.028_bib172","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T\u00a0cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib173","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jaci.2015.03.043","article-title":"IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation","volume":"136","author":"Roediger","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib174","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-5793(96)00835-6","article-title":"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells","volume":"393","author":"Rolling","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.immuni.2019.03.028_bib175","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib176","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2019.03.028_bib177","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of Interleukin-2 in T Lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib178","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.immuni.2016.07.022","article-title":"Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells","volume":"45","author":"Ross","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib179","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.8266078","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor","volume":"262","author":"Russell","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib180","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.7973658","article-title":"Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID","volume":"266","author":"Russell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib181","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib182","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib183","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib184","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","article-title":"Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene","volume":"75","author":"Sadlack","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/eji.1830240144","article-title":"Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4","volume":"24","author":"Sadlack","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib186","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1016\/S0021-9258(18)54552-X","article-title":"Biochemical evidence for a third chain of the interleukin-2 receptor","volume":"266","author":"Saito","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib187","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ecco-jcc\/jjy085","article-title":"Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study","volume":"12","author":"Sands","year":"2018","journal-title":"J.\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.immuni.2019.03.028_bib188","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1479-5876-11-37","article-title":"IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T\u00a0cells","volume":"11","author":"Santegoets","year":"2013","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib189","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/eji.1830191130","article-title":"TCGF III\/P40 is produced by naive murine CD4+ T\u00a0cells but is not a general T\u00a0cell growth factor","volume":"19","author":"Schmitt","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.immuni.2018.12.014","article-title":"Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology","volume":"50","author":"Schwartz","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fsi.2016.03.035","article-title":"What\u2019s new in fish cytokine research?","volume":"53","author":"Secombes","year":"2016","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2018.148","article-title":"Regulatory T\u00a0cells in the treatment of disease","author":"Sharabi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2019.03.028_bib193","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.3095922","article-title":"Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions","volume":"234","author":"Sharon","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib194","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.immuni.2018.01.004","article-title":"Glucocorticoids Drive Diurnal Oscillations in T Cell Distribution and Responses by Inducing Interleukin-7 Receptor and CXCR4","volume":"48","author":"Shimba","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib195","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.7690989","article-title":"A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma","volume":"261","author":"Shuai","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib196","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.3116668","article-title":"The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities","volume":"238","author":"Siegel","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib197","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","article-title":"De novo design of potent and selective mimics of IL-2 and IL-15","volume":"565","author":"Silva","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib198","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature23875","article-title":"Discovery of stimulation-responsive immune enhancers with CRISPR activation","volume":"549","author":"Simeonov","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib199","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nchembio.2056","article-title":"Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling","volume":"12","author":"Smith","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib201","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T\u00a0cells using orthogonal IL-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/MCB.20.1.389-401.2000","article-title":"DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites","volume":"20","author":"Soldaini","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib203","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1067\/mai.2001.114238","article-title":"Role of IL-9 in the pathophysiology of allergic diseases","volume":"107","author":"Soussi-Gounni","year":"2001","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib204","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: a double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2019.03.028_bib205","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1126\/science.7770771","article-title":"Deregulated T\u00a0cell activation and autoimmunity in mice lacking interleukin-2 receptor beta","volume":"268","author":"Suzuki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib206","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors","volume":"145","author":"Swain","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib207","doi-asserted-by":"crossref","first-page":"14444","DOI":"10.1073\/pnas.94.26.14444","article-title":"Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides","volume":"94","author":"Tagaya","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/intimm\/2.5.477","article-title":"An associated molecule, p64, with high-affinity interleukin 2 receptor","volume":"2","author":"Takeshita","year":"1990","journal-title":"Int. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib209","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.1631559","article-title":"Cloning of the gamma chain of the human IL-2 receptor","volume":"257","author":"Takeshita","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/302305a0","article-title":"Structure and expression of a cloned cDNA for human interleukin-2","volume":"302","author":"Taniguchi","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib211","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1084\/jem.165.1.223","article-title":"Interleukin 2 high-affinity receptor expression requires two distinct binding proteins","volume":"165","author":"Teshigawara","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib212","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1021\/acs.jmedchem.6b01694","article-title":"Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans","volume":"60","author":"Thorarensen","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.immuni.2019.03.028_bib213","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)00056-X","article-title":"IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T\u00a0cell development","volume":"13","author":"Townsend","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib214","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","article-title":"A human anti-IL-2 antibody that potentiates regulatory T\u00a0cells by a structure-based mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib215","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1073\/pnas.83.24.9694","article-title":"Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex","volume":"83","author":"Tsudo","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib216","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.85.18.6934","article-title":"Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity","volume":"85","author":"Uyttenhove","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib217","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2012.09.044","article-title":"STATs shape the active enhancer landscape of T\u00a0cell populations","volume":"151","author":"Vahedi","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib218","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature14154","article-title":"Super-enhancers delineate disease-associated regulatory nodes in T\u00a0cells","volume":"520","author":"Vahedi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib219","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.028_bib220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","article-title":"Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease","volume":"31","author":"Van Dyken","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib221","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.4049\/jimmunol.181.5.3285","article-title":"IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T\u00a0cell development","volume":"181","author":"Vang","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib222","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0092-8674(92)90105-L","article-title":"A protein tyrosine kinase in the interferon alpha\/beta signaling pathway","volume":"70","author":"Velazquez","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib223","doi-asserted-by":"crossref","first-page":"e08384","DOI":"10.7554\/eLife.08384","article-title":"Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T\u00a0cell effector and regulatory functions","volume":"5","author":"Villarino","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2019.03.028_bib224","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1084\/jem.20150907","article-title":"Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cells","volume":"214","author":"Villarino","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib225","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1002\/j.1460-2075.1996.tb00946.x","article-title":"DNA binding of in\u00a0vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites","volume":"15","author":"Vinkemeier","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2019.03.028_bib226","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1084\/jem.162.5.1726","article-title":"Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1","volume":"162","author":"Vitetta","year":"1985","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib227","doi-asserted-by":"crossref","first-page":"eaao2304","DOI":"10.1126\/scitranslmed.aao2304","article-title":"Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation","volume":"10","author":"Vogelaar","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib228","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","article-title":"A fundamental role for interleukin-21 in the generation of T follicular helper cells","volume":"29","author":"Vogelzang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib229","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","article-title":"Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine","volume":"181","author":"von Freeden-Jeffry","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib230","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T\u00a0cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2019.03.028_bib231","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib232","doi-asserted-by":"crossref","first-page":"a028472","DOI":"10.1101\/cshperspect.a028472","article-title":"Cytokines in Cancer Immunotherapy","volume":"10","author":"Waldmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.immuni.2019.03.028_bib233","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","article-title":"The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens","volume":"17","author":"Waldmann","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib234","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI76210","article-title":"MHCII-independent CD4+ T\u00a0cells protect injured CNS neurons via IL-4","volume":"125","author":"Walsh","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.028_bib235","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2013.02.011","article-title":"The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells","volume":"38","author":"Wan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib236","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1073\/pnas.1511711112","article-title":"Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T\u00a0cells","volume":"112","author":"Wan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib237","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.166.4.1055","article-title":"The interleukin 2 receptor. Functional consequences of its bimolecular structure","volume":"166","author":"Wang","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib238","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.1117893","article-title":"Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors","volume":"310","author":"Wang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib239","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.24.021605.090616","article-title":"Structural biology of shared cytokine receptors","volume":"27","author":"Wang","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib240","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.1800907","article-title":"IL-2\/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells","volume":"201","author":"Ward","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddmec.2012.09.003","article-title":"TSLP: A Key Regulator of Asthma Pathogenesis","volume":"9","author":"West","year":"2012","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.1016\/j.immuni.2019.03.028_bib242","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1172\/JCI67008","article-title":"PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T\u00a0cells","volume":"123","author":"West","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.028_bib243","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.028_bib244","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","article-title":"Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment","volume":"3","author":"Willerford","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib245","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/370153a0","article-title":"Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells","volume":"370","author":"Witthuhn","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.028_bib246","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.immuni.2016.06.025","article-title":"Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation","volume":"45","author":"Woytschak","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib247","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nm.2365","article-title":"A role for interleukin-2 trans-presentation in dendritic cell-mediated T\u00a0cell activation in humans, as revealed by daclizumab therapy","volume":"17","author":"Wuest","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib248","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1182\/blood-2016-11-749838","article-title":"Osteoblasts support megakaryopoiesis through production of interleukin-9","volume":"129","author":"Xiao","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib249","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.273.5276.794","article-title":"Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain","volume":"273","author":"Xu","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.028_bib250","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in\u00a0vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib251","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1073\/pnas.212214999","article-title":"IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes","volume":"99","author":"Xue","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.028_bib252","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.028_bib253","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.028_bib254","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T\u00a0cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.028_bib255","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2006-10-054973","article-title":"The molecular basis of IL-21-mediated proliferation","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2019.03.028_bib256","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1852","article-title":"Sensing the outside world: TSLP regulates barrier immunity","volume":"11","author":"Ziegler","year":"2010","journal-title":"Nat. Immunol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761319301451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761319301451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:09:04Z","timestamp":1761034144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761319301451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":260,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1074761319301451"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2019.03.028","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b3c Family of Cytokines: Basic Biology to Therapeutic Ramifications","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2019.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}